Predict your next investment

Corporation
medrad.com

See what CB Insights has to offer

About MEDRAD

MEDRAD develops, markets and services medical devices used to diagnose and treat disease. Its product offerings include fluid injection systems for radiology and cardiology, endovascular devices for the treatment of cardiovascular disease, magnetic resonance-compatible accessories and equipment services.

MEDRAD Headquarter Location

100 Global View Drive

Warrendale, Pennsylvania, 15086,

United States

724-940-6800

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing MEDRAD

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find MEDRAD in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

Latest MEDRAD News

FDA clears expanded use of Bayer's Medrad system

Dec 19, 2019

FDA clears expanded use of Bayer's Medrad system Dec. 19, 2019 11:15 AM ET The FDA grants 510(k) clearance to Bayer's ( OTCPK:BAYRY +0.1%) MEDRAD Stellant FLEX Computed Tomography (CT) Injection System with Certegra Workstation for use in Contrast Enhanced Mammography (CEM). The company says the use of iodine-based x-ray contrast agents in CEM enables better visualization of abnormalities in breast tissue that standard mammography may miss.

MEDRAD Acquisitions

2 Acquisitions

MEDRAD acquired 2 companies. Their latest acquisition was Pathway Medical Technologies on September 02, 2011.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

9/2/2011

Series E+

$99M

$123.5M

Acquired

1

2/11/2008

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/2/2011

2/11/2008

Investment Stage

Series E+

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$123.5M

Note

Acquired

Subscribe to see more

Sources

1

10

MEDRAD Team

2 Team Members

MEDRAD has 2 team members, including former Chief Information Officer, Jeanne Colwell Iasella.

Name

Work History

Title

Status

Jeanne Colwell Iasella

Aesynt, Bayer HealthCare, and Arthur Andersen

Chief Information Officer

Former

Kraig J McEwen

Senior Vice President

Former

Name

Jeanne Colwell Iasella

Kraig J McEwen

Work History

Aesynt, Bayer HealthCare, and Arthur Andersen

Title

Chief Information Officer

Senior Vice President

Status

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.